CD44 and triple-negative breast carcinoma: CD44 knockdown in brain seeking triple negative breast cancer cell line (MDA-MB-231-BR) reduced the pericellular HA coat on cancer cells, and consequently, their adhesion and invasion through the BE, suggesting the interaction between HA and CD44 as a potential therapeutic target of BM [32].